⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11184288 | 0.90 | — | — | |
| SCHEMBL8453338 | 0.88 | TRPV1 (0.31) | — | |
| SCHEMBL8403266 | 0.88 | — | — | |
| SCHEMBL8459228 | 0.88 | TRPV1 (0.31) | — | |
| SCHEMBL8459458 | 0.88 | TRPV1 (0.31) | — | |
| SCHEMBL11163355 | 0.88 | TRPV1 (0.31) | — | |
| SCHEMBL622595 | 0.82 | TRPV1 (0.32) | — | |
| SCHEMBL580137 | 0.79 | — | — | |
| SCHEMBL935458 | 0.76 | — | — | |
| SCHEMBL10619825 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7238709-B2 | Therapeutic carbamates | THERAVANCE, INC. (US) | 2007-07-03 | — | — | US | claimed |
| CN-111497383-B | Resin film for laminated glass, and process for producing the same | SKC株式会社 | 2022-12-16 | — | — | CN | disclosed |
| CN-107428651-B | Liquid crystalline compound, liquid crystal composition, liquid crystal-encapsulated composite fiber, fiber aggregate, fiber composite, and liquid crystal display element | 捷恩智株式会社 | 2021-06-22 | — | — | CN | disclosed |
| CN-111497383-A | Resin film for laminated glass, and process for producing the same | SKC株式会社 | 2020-08-07 | — | — | CN | disclosed |
| CN-109130391-B | Resin film for laminated glass, and process for producing the same | SKC株式会社 | 2020-05-22 | — | — | CN | disclosed |
| EP-1957073-B1 | MEDICINAL DRUG | OTSUKA PHARMA CO LTD (JP) | 2014-04-23 | — | — | EP | disclosed |
| US-8551999-B2 | Heterocyclic compound and pharmaceutical composition thereof | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-10-08 | — | — | US | disclosed |
| EP-2612858-A1 | STAT3/5 activation inhibitor | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-07-10 | — | — | EP | disclosed |
| US-20120322807-A1 | STAT3/5 ACTIVATION INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. | 2012-12-20 | — | — | US | disclosed |
| US-20120238750-A1 | AROMATIC COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. | 2012-09-20 | — | — | US | disclosed |
| US-4855310-A | Thiadiazole compounds as antagonists of SRS-A | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1989-08-08 | — | — | US | disclosed |
| EP-0133164-B1 | COMPOUNDS WHICH CAN BE COPOLYMERISED | CIBA-GEIGY AG (CH) | 1988-12-14 | — | — | EP | disclosed |
| US-4785063-A | LIGHT STABILIZERS | CIBA-GEIGY CORPORATION (US) | 1988-11-15 | — | — | US | disclosed |
| US-4693742-A | Herbicidal hydroxyamino phosphonic acids and derivatives | ROHM AND HASS COMPANY (US) | 1987-09-15 | — | — | US | disclosed |
| EP-0181779-A1 | Heterocyclic compounds, their production, and medicaments containing them | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1986-05-21 | — | — | EP | disclosed |
| US-4564619-A | ANTICOAGULANTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1986-01-14 | — | — | US | disclosed |
| EP-0133164-A2 | Compounds which can be copolymerised | CIBA-GEIGY AG (CH) | 1985-02-13 | — | — | EP | disclosed |
| US-4206156-A | ANTIMICROBIAL | FUJISAWA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1980-06-03 | — | — | US | disclosed |
| US-4182758-A | BACTERICIDES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-01-08 | — | — | US | disclosed |
| US-4060618-A | Quaternary xanthinylalkyl nortropine | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1977-11-29 | — | — | US | disclosed |